Effects of Pemafibrate on Cardio-Ankle Vascular Index (CAVI) in Patients with Type 2 Diabetes or Ischemic Heart Disease: A 24-Week Observational Study

Effects of Pemafibrate on Cardio-Ankle Vascular Index (CAVI) in Patients with Type 2 Diabetes or Ischemic Heart Disease: A 24-Week Observational Study

Yasuhiro Watanabe,1 Shoya Nonaka,2 Shuhei Yamaoka,1 Shoko Nakamura,1 Osamu Horikawa,1 Takashi Yamaguchi,1 Shuji Sato,2 Shunsuke Todani,2 Yuta Sugizaki,2 Takuro Ito,2 Hiroshi Mikamo,2 Mao Takahashi,2 Daiji Nagayama,3 Kazuhiro Shimizu,1 Atsuhito Saiki1 1Center of Diabetes, Endocrine and Metabolism, To...

Full description

Saved in:
Bibliographic Details
Main Authors: Watanabe Y, Nonaka S, Yamaoka S, Nakamura S, Horikawa O, Yamaguchi T, Sato S, Todani S, Sugizaki Y, Ito T, Mikamo H, Takahashi M, Nagayama D, Shimizu K, Saiki A
Format: Article
Language:English
Published: Dove Medical Press 2025-04-01
Series:Vascular Health and Risk Management
Subjects:
pemafibrate
cardio-ankle vascular index
type 2 diabetes mellitus
hypertriglyceridemia
Online Access:https://www.dovepress.com/effects-of-pemafibrate-on-cardio-ankle-vascular-index-cavi-in-patients-peer-reviewed-fulltext-article-VHRM
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items